Reliably predicting whether meningioma, the most common primary brain tumor, will recur or remain benign has not been easy. In this study, published in Science Advances, researchers at Baylor College ...

The diagnosis of a brain tumor—even one that's usually "benign" and slow growing such as a meningioma—can be scary. Meningiomas can cause temporary and permanent side effects and sometimes may recur ...

Researchers focused on accelerating and testing new treatments for low-grade brain tumors are set to receive a transformative £2.8 million to drive their future work.

Meningiomas are the most common primary tumors of the central nervous system. They are treated with surgery and radiation, but drug therapy is usually not effective against these tumors of the brain ...

Meningioma is a common type of skull base tumor and typically non-cancerous. However, they can still cause symptoms depending on their location and how they grow. Neurosurgeon William Couldwell, MD, ...

The costs of an intracranial meningioma diagnosis can be substantial. Not only can this diagnosis lead to a lifetime of medical bills and other costs, but it can drastically reduce patients’ quality ...

Integrating multiple molecular profiling approaches of meningioma, the most common primary brain tumor, could transform patient care by providing a better prognosis and revealing the tumors that ...